Overview
Yuzuru Yamamoto practices practicing medicine in Kobe, Japan.
Their clinical expertise encompasses Mixed Connective Tissue Disease, Arthritis, and Rheumatoid Arthritis (RA).
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yuzuru Yamamoto
Is Yuzuru Yamamoto a top-rated expert for Mixed Connective Tissue Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Yuzuru Yamamoto is classified as an Experienced expert for Mixed Connective Tissue Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yuzuru Yamamoto participate in research or clinical trials?
Yes. Yuzuru Yamamoto has published 10 articles and abstracts on conditions like Mixed Connective Tissue Disease. You can view a list of Yuzuru Yamamoto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ArthritisYamamoto isExperienced. Learn about Arthritis.
- Mixed Connective Tissue DiseaseYamamoto isExperienced. Learn about Mixed Connective Tissue Disease.
- Rheumatoid Arthritis (RA)Yamamoto isExperienced. Learn about Rheumatoid Arthritis (RA).